Cancer@Work - a nurse-led, stepped-care, e-health intervention to enhance the return to work of patients with cancer: study protocol for a randomized controlled trial

被引:18
|
作者
Tamminga, Sietske J. [1 ]
Hoving, Jan L. [1 ]
Frings-Dresen, Monique H. W. [1 ]
de Boer, Angela G. E. M. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, Amsterdam, Netherlands
来源
TRIALS | 2016年 / 17卷
关键词
Cancer survivors; Employment; Return to work; E-health; Psycho-oncological care; Study protocol; Randomised controlled trial; SELF-MANAGEMENT PROGRAM; TO-WORK; ECONOMIC-EVALUATION; COLORECTAL-CANCER; SURVIVORS; LIMITATIONS; EMPLOYEES; DESIGN; QUESTIONNAIRE; EXPLANATION;
D O I
10.1186/s13063-016-1578-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Although the importance of work for patients with cancer is nowadays more acknowledged both in the literature as well as in cancer survivorship care, effective interventions targeting the return to work of these patients are still scarce. Therefore, we developed a nurse-led, stepped-care, e-health intervention aimed at enhancing the return to work of patients with cancer. The objective of this study is to describe the content of the intervention and the study design used to evaluate the feasibility and (cost) effectiveness of the intervention. Methods: We designed a multi-centre randomised controlled trial with a follow-up of 12 months. Patients who have paid employment at the time of diagnosis, are on sick leave and are between 18-62 years old will be eligible to participate. After patients have signed the informed consent form and filled in the baseline questionnaire, they are randomly allocated to either the nurse-led, stepped-care, e-health intervention called Cancer@Work, or care as usual. The primary outcome is sustainable return to work. Secondary outcomes are sick leave days, work ability, work functioning, quality of life, quality of working life and time from initial sick leave to full return to work without extensive need for recovery. The feasibility of the Cancer@Work intervention and direct and indirect costs will be determined. Outcomes will be assessed by questionnaires at 3, 6, 9 and 12 months of follow-up. Discussion: The results of this study will provide new insights into the feasibility and (cost) effectiveness of Cancer@Work, a nurse-led, stepped-care, e-health intervention for cancer patients aimed at enhancing their return to work. If proven effective, the intention is to implement the Cancer@Work intervention in usual psychooncological care.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Cancer@Work — a nurse-led, stepped-care, e-health intervention to enhance the return to work of patients with cancer: study protocol for a randomized controlled trial
    Sietske J. Tamminga
    Jan L. Hoving
    Monique H. W. Frings-Dresen
    Angela G. E. M. de Boer
    Trials, 17
  • [2] Enhancing the Return to Work of Cancer Survivors: Development and Feasibility of the Nurse-Led eHealth Intervention Cancer@Work
    Tamminga, Sietske J.
    van Hezel, Sanne
    de Boer, Angela G. E. M.
    Frings-Dresen, Monique H. W.
    JMIR RESEARCH PROTOCOLS, 2016, 5 (02):
  • [3] A nurse-led clinic stepped-care intervention for rectal cancer survivors with bowel problems
    Pape, E.
    Van Nieuwenhove, Y.
    Van de Putte, D.
    Geboes, K.
    van Ramshorst, G.
    ANNALS OF ONCOLOGY, 2024, 35 : S1190 - S1190
  • [4] A Randomized Trial of a Nurse-Led Palliative Care Intervention for Patients with Newly Diagnosed Lung Cancer
    Reinke, Lynn F.
    Sullivan, Donald R.
    Slatore, Christopher
    Dransfield, Mark T.
    Ruedebusch, Susan
    Smith, Patti
    Rise, Peter J.
    Tartaglione, Erica V.
    Vig, Elizabeth K.
    Au, David H.
    JOURNAL OF PALLIATIVE MEDICINE, 2022, 25 (11) : 1668 - 1676
  • [5] Evaluating a nurse-led survivorship care package (SurvivorCare) for bowel cancer survivors: study protocol for a randomized controlled trial
    Michael Jefford
    Sanchia Aranda
    Karla Gough
    Kerryann Lotfi-Jam
    Phyllis Butow
    Mei Krishnasamy
    Jane Young
    Jo Phipps-Nelson
    Lahiru Russell
    Dorothy King
    Penelope Schofield
    Trials, 14
  • [6] Evaluating a nurse-led survivorship care package (SurvivorCare) for bowel cancer survivors: study protocol for a randomized controlled trial
    Jefford, Michael
    Aranda, Sanchia
    Gough, Karla
    Lotfi-Jam, Kerryann
    Butow, Phyllis
    Krishnasamy, Mei
    Young, Jane
    Phipps-Nelson, Jo
    Russell, Lahiru
    King, Dorothy
    Schofield, Penelope
    TRIALS, 2013, 14
  • [7] Randomized Controlled Trial of a Nurse-Led Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer
    Greer, Joseph A.
    Post, Kathryn E.
    Chabria, Reena
    Aribindi, Seetha
    Brennan, Natalie
    Eche-Ugwu, Ijeoma Julie
    Halpenny, Barbara
    Fox, Erica
    Lo, Stephen
    Waldman, Lauren P.
    Pintro, Kedie
    Rabideau, Dustin J.
    Pirl, William F.
    Cooley, Mary E.
    Temel, Jennifer S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (30)
  • [8] RESTART: a stepped-care approach to facilitate return to work for employees with psychological distress: design of a randomized controlled trial
    Lettinga, Hanneke A. M.
    van Oostrom, Sandra H.
    Zijlstra, Hendrika P.
    Anema, Johannes R.
    Proper, Karin I.
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [9] A Nurse-Led Care Program for Breast Cancer Patients in a Chemotherapy Day Center A Randomized Controlled Trial
    Lai, Xiao Bin
    Ching, Shirley Siu Yin
    Wong, Frances Kam Yuet
    Leung, Carenx Wai Yee
    Lee, Lai Ha
    Wong, Jessica Shuk Yin
    Lo, Yim Fan
    CANCER NURSING, 2019, 42 (01) : 20 - 34
  • [10] A nurse-led intervention in patients with newly diagnosed cancer and Type 2 diabetes: A pilot randomized controlled trial feasibility study
    Scarton, Lisa
    Nelson, Tarah
    Jo, Ara
    O'Neal, LaToya J.
    Yao, Yingwei
    Huggins, Shavondra
    Legaspi, Anatolia B.
    McClaren, Mariah J.
    Cabassa, Jake S.
    Melendez, Joan Burgos M.
    Munoz-Pena, Juan M.
    Markham, Merry J.
    Murphy, Martina C.
    Chatzkel, Jonathan A.
    Rogers, Sherise
    George, Thomas J.
    CANCER MEDICINE, 2023, 12 (11): : 12874 - 12880